CEO
James Hamet, a visionary neurotech entrepreneur, founded Vistim Labs, leveraging AI and software to redefine dementia evaluation. With a notable track record, including co-founding the $100M Neurable, James' journey began in empowering paralyzed patients and expanded to groundbreaking diagnostics. A respected neurotechnology expert, he collaborates globally and has authored impactful research. Vistim Labs addresses inconclusive neurological tests through AI-driven predictive screening. James epitomizes a tech CEO committed to innovation, bridging research and practical healthcare solutions.